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SUMMARY 
 
The aim of this study was to investigate the chemical composition and 
antifungal activity of four essential oils from Apiaceae family, Pastinaca 
sativa, Foeniculum vulgare, Pimpinella anisum and Anethum 
graveolens, against Candida spp. reference strains and clinical isolates 
from human oral cavities. Chemical analysis of the essential oils (GC-
FID and GC/MS) showed that predominating chemical classes in the 
essential oil of A. graveolens was monoterpene hydrocarbons (49.4 %) 
and the major constituent of the oil was carvone (42.2 %): while in the 
oils of P. anisum, F. vulgare and P. sativa majority of compounds 
belong to phenylpropenes (80.9 %, 65.9 % and 49.4 %, respectively): 
and the major oil constituents were trans-anethole (65.1 % and 80.8 %) 
and myristicine (49.0 %): respectively. Minimum inhibitory (MIC) and 
minimum fungicidal (MFC) concentrations were determined using 
microdilution method. All the tested oils inhibited growth of Candida 
spp. The strongest antifungal activity was shown by A. graveolens 
essential oil (MIC 0.63-2.5 mg mL-1; MFC 1.25-5 mg mL-1). In addition 
to the common use of parsnip, fennel, anise and dill in traditional 
medicine, present study validates use of their essential oils in treatments 
intended for reduction and elimination of Candida spp. population in 
human patients with fungal infection. 
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INTRODUCTION 
 
The genus Candida forms a part of the normal oral microbiota. C. albicans 
is an opportunistic pathogen and a major causative agent of superficial as well as 
life treating dissemination infections [1]. Besides C. albicans, other Candida 
species, such as C. krusei, C. tropicalis, C. parapsilopsis, C. dubleniensis are even 
more frequently isolated as a consequence of invasive treatments in 
immunocompromised patients and use of wide spectrum antibiotics [2]. Currently 
available synthetic drugs intended for treatment of fungal infections, Fluconazole 
and Nystatin, bring about challenge such as development of resistant strains and 
thus limited clinical effectiveness [3]. These impose necessity to find out safer and 
more efficient antifungal agent for proper management and treatment of Candida – 
related infections. 
Interest in therapeutic use of non-conventional, non-prescription, or so–
called natural medicines in the field of infectious diseases increased remarkably in 
recent years. Plants present valuable sources of new bioactive compounds, mostly 
driven by the well-known side effects of conventional drugs as well as by the spread 
of antimicrobial resistance to otherwise efficient and well-tolerated drugs [4]. 
Apiaceae (Umbilliferae) family comprises more than 3700 speciesspread 
across 455 genera [5]. This family includes well known plants such as: anise, 
carrot, dill, fennel, parsley, parsnip, celery etc. Plants from Apiaceae family are 
known as condiments due to their flavor, and are also appreciated in perfumery and 
medicine [6]. They have been used as household remedies against digestive, 
gynecologic, neurologic, respiratory and gastrointestinal disorders (e.g. indigestion, 
flatulence, colic pain etc.): and their dry ripe fruits and essential oils have aromatic, 
carminative, stomachic and diuretic properties [7]. The essential oils (EO) of these 
plants have been also reported to possess antimicrobial activity [8-11]. 
The objective of this study was to evaluate chemical composition and 
determine minimum inhibitory and minimum fungicidal concentrations of four 
essential oils belonging to Apiaceae family, Pastinaca sativa, Foeniculum vulgare, 
Pimpinella anisum and Anethum graveolens, against reference and oral Candida 
spp. clinical isolates. The results were compared with positive control, Nystatin. 
 
 
MATERIAL AND METHODS 
 
Essential oils 
Four essential oils (EOs) from Apiaceae family were used in this 
experiment. The seed oils from Foeniculum vulgare, Pimpinella anisum and 
Anethum graveolens were purchased from Herbal Pharmacy of the Institute for 
Medicinal Plants “Dr Josif Pančić” Belgrade, Serbia, while the root oil from 
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Pastinaca sativa was extracted in the laboratory, according to following procedure: 
dried root of P. sativa was ground to a powder (300 g): and subjected to distillation 
for 3 hours using a Clevenger-type apparatus. The crude oil was dried over 
anhydrous sodium sulphate to remove remaining water. All essential oils were kept 
in a refrigerator at 4°C, in the dark, until used in this experiment. 
 
Essential oils isolation and analyses procedure 
The procedure used for Gas Chromatography coupled with a Flame-
Ionization Detector (GC-FID) and Gas Chromatography / Mass Spectrometry 
(GC/MS) analyses complies with standards set for gas chromatography of essential 
oils (ISO 7609:1985; ISO11024 -1:1998, and 11024 -2:1998). 
GC-FID analysis was performed using a GC Agilent Technologies 7890 
Apparatus, equipped with the split-splitless injector and automatic liquid sampler 
(ALS): attached to HP-5 column (30 m x 0.32 mm, film thickness 0.25 μm) and 
fitted with aflame-ionization detector (FID). Operating conditions were as follows: 
carrier gas was H2 (1ml/min/210 °C); temperatures of injector and detector were 
set at 250 °C and 280 °C, respectively, while the column temperature was linearly 
programmed 40–260°C at 4°C/min. 
Solutions of F. vulgare, P. anisum and A. graveolens essential oils’ 
samples in ethanol and P. sativa oil sample in petroleum ether (approx. 1%) were 
consecutively injected by ALS (1 μl, split-mode).The percentile presence of 
components in essential oils’ samples were calculated from the peak areas obtained 
in the area-percent reports (obtained as a result of standard processing of 
chromatograms) without correction factors, using normalization method. 
The GC/MS was performed on an HP G1800C Series II GCD analytical 
system equipped with an HP-5MS column (30 m×0.25 mm, film thickness 0.25 
μm). The carrier gas was He (1 ml/min). Other chromatographic conditions were 
the same as those for GC-FID. The transfer line was heated at 260°C. Mass spectra 
were recorded in EI mode (70eV): in a range of m/z 40–450. Solutions of F. 
vulgare, P. anisum and A. graveolens essential oils’ samples in ethanol and P. 
sativa oil sample in petroleum (approx. 1%) were consecutively injected by ALS 
(0.2 μl, split mode). 
The identification of essential oils components was based on matching of 
their mass spectra peaks with those from the Wiley 275 and NIST/NBS libraries. 
The experimental values for Kovats’ retention indices (RI) were determined by 
using calibrated Automated 
Mass Spectral Deconvolution and Identification System software (AMDIS 
ver. 2.1.): compared to those from available literature [12], and they were used 
asadditional tools to support the MS findings. 
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Microorganisms 
In this study, fifty four clinical isolates of Candida spp.and two ATCC 
strainswere used of (Candida albicansATCC 10231 and Candida tropicalis ATCC 
750). Reference strains were obtained from the Laboratory for Mycology at the 
Institute for Biological Research “Siniša Stanković” University of Belgrade, 
Serbia. All clinical isolates were obtained by rubbing sterile cotton swabs over oral 
mucosa from randomly chosen patients at the Department of Pediatric and 
Preventive Dentistry, Faculty of Dental Medicine, University of Belgrade, Serbia. 
The swabs were transferred to SD broth medium for Candida and thoroughly 
mixed using vortex mixer and 50 μl of suspension inoculated on various selective 
and non-selective medium and incubated microaerobically for 48 h at 37°C. Isolates 
were identified using biochemical profiles with API 20C (bioMérieux France) and 
Chrom-Agar (Liofilchems.r.l. Italy). 
 
Antifungal activity 
Minimum inhibitory (MIC) and minimum fungicidal (MFC) concentrations 
were determined by microdilutiom method in 96 well microtitre plates [13]. 
Briefly, fresh overnight cultures of yeasts were adjusted with sterile saline to a 
concentration of 1.0X105 CFU/per well. The microplates were incubated for 24h at 
37°C. The MIC of the samples was detected following addition of 40 μl of P-
Iodonitrotetrazolium violet (INT) 0.2 mg mL-1 (Sigma I8377) and incubation at 
37°C for 30 min. The MIC was considered as a lowest concentration with no visible 
growth detected under microscope. The MFCs were determined by serial sub-
cultivation of 10 µl into microtitre plates containing 100 µl of broth per well and 
further incubation for 24h at 37°C. The lowest concentration with no visible growth 
was defined as MFC, indicating 99.5% killing of an original inoculum. Nystatin 
(Hemofarm, Serbia) was used as a positive control. 
 
 
RESULTS AND DISCUSSION 
 
Chemical composition of investigated Apiaceae family essential oils is 
presented in Table 1. 
The hydrodistillation of P. sativadry roots yielded 0.16% (w/w) of 
essential oil. The oil proved to be almost equally rich in phenylpropenes and 
monoterpene hydrocarbons, which together accounted for 97,7% of the total oil 
content. The major oil constituents were myristicine (49.0%) and terpinolene 
(39.8%): as also reported in another study [14], though the contents of those two 
constituents quite differed. Similarly to P. sativa, the EOs from P. anisum and F. 
vulgare were abundant in phelypropenes (80.8% and 65.1%, respectively); the 
major constituent of both oils was trans-anethole.  
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Table 1. Chemical composition of four tested essential oils from Apiaceae family. 
Tabela 1. Hemijski sastav ispitivana četri etarska ulja iz familije Apiaceae. 
 
Essential oil  
constituents RI* 
Contribution to the oil   (% m/m) 
F. vulgare P. anisum P. sativa A. graveolens 
1 Tricyclene 918 0.1 0.1 
2 Thujene<alpha-> 923 0.6 0.4 0.6 
3 Pinene <alpha-> 924 1.5 
4 Camphene 938 0.2
5 Sabinene 966 tr 3.2 
6 Pinene <beta-> 967 0.1 
7 Myrcene 983 tr 0.7 0.4 
8 Phellandrene<alpha-> 995 0.4 0.4 14.2 
9 Caren <delta-3-> 1003 tr 
10 Terpinene<alpha-> 1008 0.1 
11 Cymene<para-> 1016 0.3 0.1 2.0 
12 Limonene 1020 1.3 2.0 32.0 
13 Cineol <1,8-> 1023 0.2 4.7 
14 Ocimene<cis-beta-> 1031 0.7 
15 Ocimene<trans-beta-> 1041 0.2 
16 Terpinene<gamma-> 1050 0.3 0.2 
17 Fenchone 1080 25.6 
18 Terpinolene 1086 39.8 
19 Linalool 1096 1.5 
20 Menthatriene<1,3,8-para-> 1103 0.2 
21 Ocimene<allo-> 1123 0.3 
22 Thujanol<iso-3-> 1130 0.1 
23 Camphor 1135 0.7 
24 Menthone 1146 0.4 
25 Menthone<iso-> 1156 0.2 
26 Menthol <neo-> 1166 0.3 
27 Terpinene-4-ol 1169 0.6 0.1 
28 Dill ether 1176 6.7 
29 Cymen-8-ol<para-> 1178 0.9 
30 Terpineol<alpha-> 1186 0.8 
31 Dihydrocarvone<cis-> 1189 1.3 
32 Methyl chavicol 1192 3.4 6.3 
33 Dihydrocarvone<trans-> 1196 1.0 
34 Dihydrocarveol<iso-> 1210 0.1 
35 Verbenyl acetate<cis-> 1217 0.1 
36 Dihydrocarveol<neoiso-> 1223 0.3 
37 Carvone 1238 40.2 
38 Anethole<cis-> 1247 0.8 0.1 
39 Anethole<trans-> 1283 65.1 80.8 
40 Verbenyl acetate<trans-> 1291 0.1 
41 Copaene<alpha-> 1366 0.7 
42 Anisyl methyl ketone 1390 1.9 
43 Longipinene<beta-> 1396 0.2
44 Caryophyllene<cis-beta-> 1407 0.1 
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45 Bergamotene<alpha-trans-> 1425 0.2 
46 Guaiadiene<6,9-> 1440 0.1 
47 Amorpha-4,11-diene 1449 0.3 
48 Dauca-5,8-diene 1470 0.2 
49 Himachalene<gamma-> 1476 1.7 
50 Himachalene<beta-> 1498 0.3 
51 Myristicine 1515 49.0 
52 Elemecin 1553 0.3 
Monoterpene hydrocarbons 4.13 0.59 48.30 49.35 
Oxigenated monoterpenes 29.83 15.84 1.31 50.41 
Sesquiterpene hydrocarbons 0.00 2.59 0.95 0.24 
Oxigenated sesquiterpenes 0.00 0.00 0.00 0.00 
Phenylpropenes 65.85 80.88 49.37 0.00 
Sum of identified compounds 99.80 99.89 99.93 100.00 
Number of identified compounds 13 12 26 16 
* RI –Values for retention indices on the HP-5 column. 
 
 
Earlier studies also confirmed the abundance of trans-anethole in both oils [15] as 
well as a great variability in its content [16, 17]. In addition, analysis of both EOs 
also revealed a high content of oxygenated monoterpenes, but the major difference 
between them was in contents of mono and sesqiterpene hydrocarbon oil portions. 
The result of analysisof our A. graveolens EO is in consistency to another study 
[18]. In addition, the oil revealed quite differing composition comparing to the 
remaining three Apiaceae oils. The two main EO classes, monoterpene 
hydrocarbons and oxygenated monoterpenes, contributed to the oil in almost equal 
quantities, together representing 99,8 % of the total oil; the major constituents 
proved to be cis–anethole (40,2%): limonene (32,0%) and phellandrene (14.2%). 
The results of antifungal activity of selected EOs are presented in Table 2. 
Compared to the positive control with Nystatin (MIC 0.01- 0.5 mg mL-1; MFC 0.01-
1 mg mL-1), neither of the tested EOs expressed stronger antifungal activity. The 
strongest average antifungal activity was achieved by A. graveolens oil, as well as P. 
sativa (MIC 0.63-1.25 mg mL-1; MFC 1.25-5 mg mL-1) while the oils of P. anisum 
and F. vulgare inhibited growth of all tested fungi in the range of MIC 1.25-2.5 and 
1.25-5 mg mL-1, respectively, and MFC 2.5-5.0 and 2.5-10 mg mL-1, respectively.  
There are many reports of antimicrobial effect of Apiaceae family EOs, 
related to medically significant bacteria and fungi [19]. However, limited data exist 
regarding the activity against clinical specimens, particularly C. krusei and C. 
glabrata. In our study, in comparison C. albicans whose clinical isolates expressed 
great variability in their susceptibility to tested Apiace EOs (MIC 0.63-5.0 and MFC 
1.25-10 mg mL-1): clinical isolates of C. krusei (MIC 0.63-2.5 and MFC 1.25-5.0 mg 
mL-1) and C. glabrata (MIC 1.25-5 and MFC 2.5-5 mg mL-1): in general, both 
proved to be lass variable in their response to tested EOs.  
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Table 2. Antifungal activity of four essential oils from Apiaceae family (mg mL-1) 
Tabela 2. Antifungalna aktivnost četri etarska ulja iz familije Apiaceae (mg mL-1) 
 
Candida spp. 
reference  
strains and  
clinical isolates 
Essential oils Control 
P. sativa F. vulgare P. anis A. graveolens Nystatin 
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
1 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
2 C. krusei clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
3 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
4 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
5 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
6 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
7 C.a. clin. 2.5 5 2.5 5 1.25 2.5 1.25 2.5 0.007 0.01 
8 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
9 C.a. clin. 2.5 5 2.5 5 1.25 2.5 1.25 2.5 0.007 0.01 
10 C. k. clin. 1.25 5 2.5 5 1.25 2.5 0.63 1.25 0.01 0.03 
11 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
12 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
13 C.a. clin. 2.5 5 2.5 5 1.25 2.5 1.25 2.5 0.01 0.03 
14 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
15 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
16 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
17 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
18 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
19 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
20 C. g. clin. 1.25 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
21 C.a. clin. 1.25 5 2.5 5 1.25 2.5 0.63 1.25 0.007 0.01 
22 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
23 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
24 C.a. clin. 2.5 5 2.5 5 1.25 2.5 1.25 2.5 0.007 0.01 
25 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.03 0.06 
26 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
27 C. g. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
28 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
29 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
30 C.a. clin. 2.5 5 5 5 2.5 5 1.25 2.5 0.007 0.01 
31 C.a. clin. 2.5 5 2.5 5 1.25 2.5 0.63 1.25 0.007 0.01 
32 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
33 C.a. clin. 1.25 2.5 2.5 5 2.5 5 0.63 1.25 0.5 1 
34 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
35 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
36 C.a. clin. 2.5 5 1.25 2.5 1.25 2.5 2.5 5 0.007 0.01 
37 C.a. clin. 2.5 5 5 10 2.5 5 2.5 5 0.007 0.01 
38 C.a. clin. 2.5 5 5 10 2.5 5 1.25 2.5 0.03 0.06 
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39 C.a. clin. 2.5 5 5 10 2.5 5 1.25 2.5 0.007 0.01 
40 C.a. clin. 2.5 5 5 10 1.25 2.5 1.25 2.5 0.007 0.01 
41 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
42 C.a. clin. 1.25 2.5 1.25 2.5 2.5 5 0.63 1.25 0.007 0.01 
43 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
44 C.a. clin. 1.25 2.5 1.25 2.5 2.5 5 1.25 2.5 0.007 0.01 
45 ATCC10231 1.25 2.5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
46 ATCC750 0.625 1.25 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
47 C.a. clin. 1.25 2.5 2.5 5 2.5 5 0.63 1.25 0.007 0.01 
48 C.a. clin. 1.25 2.5 2.5 5 2.5 5 0.63 1.25 0.007 0.01 
49 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
50 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
51 C.a. clin. 2.5 5 2.5 5 2.5 5 0.63 1.25 0.01 0.03 
52 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
53 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
54 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.01 0.03 
55 C.a. clin. 2.5 5 5 10 2.5 5 1.25 2.5 0.007 0.01 
56 C.a. clin. 2.5 5 2.5 5 2.5 5 1.25 2.5 0.007 0.01 
C.a. clin. – C. albicans clinical isolate; C.k. clin.– C. krusei clinical isolate; C.g. clin.– C. 
glabrata clinical isolate; ATCC (The American Type Culture Collection); ATCC10231 – 
C. albicans; ATCC750 – C. tropicalis. 
 
In addition, in the present study, no great differences in their response to 
the tested Apiace EOs were observed between the tested clinical isolates and the 
reference Candida spp. strains. Regarding the general susceptibility to Apaceae 
EOs, clinical isolates of C. krusei and C. glabrata, in comparison to C. albicans, 
seemed to be more and less susceptible, respectively (Table 2).  
In the present study, all the tested microorganisms were inhibited by 
selected essential oils to a certain extent. Previous research on antifungal activity of 
F. vulgare, P. anisum, P. sativa and A. graveolens essential oils showed that they 
possess a specific activity [20-22]. However, due to different test methods applied, 
in addition to different fungal strains and sources of antimicrobial samples, the 
results from different studies are not directly comparable with ours. Similarly to 
our other study [23], in the present study, the oil of A. graveolens with its highest 
contents of both, monoterpene hydrocarbons and oxigenated monoterpenes, 
comparing to other three EOs (Table 1): was the most efficient oil against almost 
all fungi. The exception was ATCC single strain of C. tropicalis that proved to be 
the most susceptible to P. sativa oil, followed by the oil of A. graveolens; the both 
oils are rich in monoterpene hydrocarbons, while the oils of P. anisum and F. 
vulgare, that generally expressed lower antifungal activity, are poor in this class of 
compounds. 
Plant EOs have been used in folk medicine for many years. Among them, 
due to their antimicrobial activity against a wide range of pathogenic 
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microorganisms, EOs from Apiaceae species attracted a huge interest. Nowadays, 
the resistance of human pathogens to multiple drugs is well known and it indicates 
the urge to search for novel antimicrobial substances; plants represent a huge 
source of natural compounds with various biological activities and desirable 
therapeutic properties.  
During the last two decades, the yeasts of the genus Candida have received 
a great attention in medical literature. Use of herbs and its products for various 
health problems, as an alternative to the standard drugs, is prevailing in developing 
countries and already well established in some cultures and traditions. With regard 
to the mentioned raising trend, our results seem to be very encouraging. They prove 
that tested secondary metabolites (essential oils) extracted from aromatic plants of 
Apiaceae family possess natural antifungal potential; among the tested EOs, the oil 
from A. graveolens was the strongest one against all tested clinical isolates. As it is 
explained, its efficacy seems to be directly linked to its chemical composition (high 
portion of monoterpenes). However, use of the entire EOs does not allow 
determination of single active principles, and some studies shows that oils in its 
complete composition express a greater antimicrobial activity than their single 
components, suggesting a great meaning of synergistic effect of the oil’s minor and 
major constituents [24]. 
Although in comparison to Apiaceae EOs tested in our study Nystatin 
showed stronger antifungal activity, it is well known that synthetic drugs may 
cause certain adverse effects, such as toxicity, allergic reactions, and possibly lead 
to the emergence of resistance after a certain period of use, particularly in patients 
with recurrent infections with Candida. In addition, antifungal and therapeutic 
potential of herbal essential oils and their components are known for their in vitro 
and in vivo efficacy, with no harmful effects [25]. 
Development of resistance to synthetic drugs poses a serious long-term 
threat to the public health. This work suggests essential oils as naturally occurring 
antimicrobial agents that could be used in formulations of a novel, promising drug 
intended for use in treatment and prevention of Candida–related infections. Further 
and more detailed studies are required prior to their application in the regular 
clinical dental practice. 
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IZVOD 
 
Cilj ovog istraživanja bio je da se ispita hemijski sastav i antifungalna 
aktivnost četiri etarska ulja familije Apiaceae, Pastinaca sativa, Foeniculum 
vulgare, Pimpinella anisum i Anethum graveolens, na referentne sojeve i kliničke 
izolate Candida spp. iz usne duplje ljudi. Hemijska analiza ispitivanih etarskih ulja 
(GC-FID i GC/MS) je pokazala da u uljima dominiraju sledeće hemijske klase: u 
ulju A. graveolens - monoterpenski ugljovodonici (49,4%) i glavni sastojak je 
karvon (42,2 %): dok u uljima P. anisum F. vulgare P. sativa većina jedinjenja 
pripada fenilpropenima (80,9 %, 65,9 % i 49,4 %, respektivno): pri čemu su glavne 
komponente prva dva ulja trans-anetol (65,1 % i 80.8 %): a trećeg, miristicin (49.0 
%). Minimalne inhibitorne (MIC) i minimalne fungicidne koncentracije ulja (MFC) 
su određene primenom mikrodilucione metode. Ispitivana tri ulja su inhibirala rast 
svih Candida spp.; najjaču antifungalnu aktivnost je pokazalo ulje A. graveolens 
(MIC 0.63-2.5 mg ml-1; MFC 1.25-5 mg ml-1). Pored česte primene paškanata, 
morača, anisa i mirođije u tradicionalnoj medicini, ova studija potvrđuje upotrebu 
njihovih etarskih ulja u tretmanima redukcije i eliminisanju populacije Candida 
spp. kod humanih pacijenata sa gljivičnim infekcijama. 
 
Ključne reči: Apiaceae, etarska ulja, Candida spp., antifungalna aktivnost. 
 
 
 
 
 
